AbbVie is is currently undergoing testing and trials of KALETRA® /Aluvia (lopinavir/ritonavir)* against COVID-19.
Rankings by 
National Ranking
66th
in United StatesRegional Ranking
72nd
in North America and CaribbeanGlobal Ranking
176th
worldwide